Innealta Capital’s OptimizeRx OPRX Stock Holding History

Innealta Capital’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$10	–	1206
2024 Q2	$10	Buy	+1	New	+$11	﹤0.01%	1821

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Samjo Management New York $293M AUM 57.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Innealta Capital's OPRX Position: Q3 2024 in Review

Innealta Capital sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 1 share — an estimated $10 sold.

Innealta Capital first reported a position in OPRX in Q2 2024 and held it in 1 quarter. The position peaked at $10 in Q2 2024. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

Innealta Capital reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 1 OptimizeRx share in Q3 2024, an estimated $10.
Innealta Capital first reported a position in OptimizeRx in Q2 2024 and held it in 1 quarter.
Innealta Capital's OptimizeRx position peaked at $10 in Q2 2024.
85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.